This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Joint Stock Company "Biocad". Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ivan Vladimirovich Mitroshin: Innovator in Biotechnology
Introduction: Ivan Vladimirovich Mitroshin is a prominent inventor based in Izhevsk, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions that address medical challenges.
Latest Patents: Ivan holds a patent for a monoclonal antibody that binds specifically to GITR. This invention relates to biotechnology and includes antibodies or antigen-binding fragments, as well as their applications. The patent encompasses a nucleic acid encoding the antibody, an expression vector, and methods for preparing the antibody. It also highlights the use of this antibody in treating diseases or disorders associated with GITR. Ivan has 1 patent to his name.
Career Highlights: Ivan is currently employed at Biocad, a leading biotechnology company. His role involves research and development of innovative biopharmaceuticals. His expertise in monoclonal antibodies has positioned him as a key figure in the advancement of therapeutic solutions.
Collaborations: Ivan has collaborated with notable colleagues, including Anastasia Nikolaevna Ishutinova and Olesya Nikolaevna Kozlova. These partnerships have fostered a collaborative environment that enhances research outcomes.
Conclusion: Ivan Vladimirovich Mitroshin is a dedicated inventor whose work in biotechnology is paving the way for new medical treatments. His contributions, particularly in monoclonal antibodies, demonstrate his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile